Original Research

Published on 07 Oct 2021

Anlotinib Combined With Anti-PD-1 Antibodies Therapy in Patients With Advanced Refractory Solid Tumors: A Single-Center, Observational, Prospective Study

in Cancer Immunity and Immunotherapy

Min Yuan
Zhongzheng Zhu
Wei Mao
Hui Wang
Hong Qian
Jianguo Wu
Xianling Guo
Qing Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.683502

5,531 views
30 citations

Case Report

Published on 06 Oct 2021

Case Report: Pulmonary Metastases From Epithelioid Sarcoma in Extremity Favourably Responding to Immunotherapy With Camrelizumab

in Cancer Immunity and Immunotherapy

Tao-Jun Gong
Fan Tang
Chuan-Xi Zheng
Jie Wang
Yi-Tian Wang
Ya-Han Zhang
Yi Luo
Yong Zhou
Li Min
Chong-Qi Tu

Frontiers in Oncology

doi 10.3389/fonc.2021.728437

3,690 views
4 citations

Original Research

Published on 01 Oct 2021

Expression of Microtubule-Associated Proteins in Relation to Prognosis and Efficacy of Immunotherapy in Non-Small Cell Lung Cancer

in Cancer Immunity and Immunotherapy

Jieyan Luo
Qipeng Hu
Maling Gou
Xiaoke Liu
Yi Qin
Jiao Zhu
Chengzhi Cai
Tian Tian
Zegui Tu
Yijia Du

Frontiers in Oncology

doi 10.3389/fonc.2021.680402

4,597 views
11 citations

Original Research

Published on 01 Oct 2021

CALR-TLR4 Complex Inhibits Non-Small Cell Lung Cancer Progression by Regulating the Migration and Maturation of Dendritic Cells

in Cancer Immunity and Immunotherapy

Ruo Chen
Min Huang
Xu Yang
Xiao-Hong Chen
Ming-Yan Shi
Zhuo-Fan Li
Zhi-Nan Chen
Ke Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.743050

3,837 views
11 citations

Review

Published on 01 Oct 2021

The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer

in Cancer Immunity and Immunotherapy

Jiayan Wei
Jia Feng
Yiming Weng
Zexi Xu
Yao Jin
Peiwei Wang
Xue Cui
Peng Ruan
Ruijun Luo
Na Li

Frontiers in Oncology

doi 10.3389/fonc.2021.706910

4,029 views
17 citations

Correction

Published on 01 Oct 2021

Corrigendum: Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL

in Cancer Immunity and Immunotherapy

Yuan Meng
Biping Deng
Luan Rong
Chuo Li
Weiliang Song
Zhuojun Ling
Jinlong Xu
Jiajia Duan
Zelin Wang
Alex H. Chang

Frontiers in Oncology

doi 10.3389/fonc.2021.778039

1,378 views

Review

Published on 01 Oct 2021

Large Granular Lymphocyte Expansion in Myeloid Diseases and Bone Marrow Failure Syndromes: Whoever Seeks Finds

in Cancer Immunity and Immunotherapy

Bruno Fattizzo
Valentina Bellani
Raffaella Pasquale
Juri Alessandro Giannotta
Wilma Barcellini

Frontiers in Oncology

doi 10.3389/fonc.2021.748610

17,264 views
13 citations

Mini Review

Published on 30 Sep 2021

Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer

in Cancer Immunity and Immunotherapy

Michael Burke
Sawsan Rashdan

Frontiers in Oncology

doi 10.3389/fonc.2021.720759

3,426 views
5 citations

Original Research

Published on 30 Sep 2021

Periodontal Pathogens Promote Oral Squamous Cell Carcinoma by Regulating ATR and NLRP3 Inflammasome

in Cancer Immunity and Immunotherapy

Yufei Yao
Xin Shen
Maolin Zhou
Boyu Tang

Frontiers in Oncology

doi 10.3389/fonc.2021.722797

6,955 views
32 citations

Original Research

Published on 29 Sep 2021

PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB “Super-Stimulation”

in Cancer Immunity and Immunotherapy

Gaia Zuccolotto
Alessandro Penna
Giulio Fracasso
Debora Carpanese
Isabella Monia Montagner
Silvia Dalla Santa
Antonio Rosato

Frontiers in Oncology

doi 10.3389/fonc.2021.708073

6,566 views
13 citations

Original Research

Published on 28 Sep 2021

TNFα Signaling Is Increased in Progressing Oral Potentially Malignant Disorders and Regulates Malignant Transformation in an Oral Carcinogenesis Model

in Cancer Immunity and Immunotherapy

Jeffrey W. Chadwick
Rachel Macdonald
Aiman A. Ali
Michael Glogauer
Marco A. Magalhaes

Frontiers in Oncology

doi 10.3389/fonc.2021.741013

3,706 views
15 citations

Original Research

Published on 27 Sep 2021

Bone Marrow Soluble Immunological Mediators as Clinical Prognosis Biomarkers in B-Cell Acute Lymphoblastic Leukemia Patients Undergoing Induction Therapy

in Cancer Immunity and Immunotherapy

Marlon Wendell Athaydes Kerr
Fábio Magalhães-Gama
Hiochelson Najibe Santos Ibiapina
Fabíola Silva Alves Hanna
Lilyane Amorim Xabregas
Eliana Brasil Alves
João Paulo Diniz Pimentel
Maria Perpétuo Socorro Sampaio Carvalho
Andréa Monteiro Tarragô
Andréa Teixeira-Carvalho

Frontiers in Oncology

doi 10.3389/fonc.2021.696032

3,506 views
6 citations

Original Research

Published on 27 Sep 2021

The Prognostic Value of a Tumor Microenvironment-Based Immune Cell Infiltration Score Model in Colon Cancer

in Cancer Immunity and Immunotherapy

Xingkui Tang
Minling Liu
Xijun Luo
Mengyuan Zhu
Shan Huang
Xiaofen Pan

Frontiers in Oncology

doi 10.3389/fonc.2021.728842

2,917 views
3 citations

Review

Published on 24 Sep 2021

Metabolic Modifications, Inflammation, and Cancer Immunotherapy

in Cancer Immunity and Immunotherapy

Sihao Zheng
Qibin Song
Pingfeng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.703681

5,940 views
10 citations

Case Report

Published on 24 Sep 2021

Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report

in Cancer Immunity and Immunotherapy

Romain Varnier
Thibaut Garrivier
Emilie Hafliger
Aymeric Favre
Clélia Coutzac
Clément Spire
Pauline Rochefort
Matthieu Sarabi
Françoise Desseigne
Pierre Guibert

Frontiers in Oncology

doi 10.3389/fonc.2021.756365

4,064 views
3 citations

Review

Published on 23 Sep 2021

Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?

in Cancer Immunity and Immunotherapy

Enrica Teresa Tanda
Elena Croce
Francesco Spagnolo
Lodovica Zullo
Stefano Spinaci
Carlo Genova
Giovanni Rossi

Frontiers in Oncology

doi 10.3389/fonc.2021.736123

4,456 views
7 citations

Navigation group

Articles

Anlotinib Combined With Anti-PD-1 Antibodies Therapy in Patients With Advanced Refractory Solid Tumors: A Single-Center, Observational, Prospective Study

Case Report: Pulmonary Metastases From Epithelioid Sarcoma in Extremity Favourably Responding to Immunotherapy With Camrelizumab

Expression of Microtubule-Associated Proteins in Relation to Prognosis and Efficacy of Immunotherapy in Non-Small Cell Lung Cancer

CALR-TLR4 Complex Inhibits Non-Small Cell Lung Cancer Progression by Regulating the Migration and Maturation of Dendritic Cells

The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer

Corrigendum: Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL

Large Granular Lymphocyte Expansion in Myeloid Diseases and Bone Marrow Failure Syndromes: Whoever Seeks Finds

Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer

Periodontal Pathogens Promote Oral Squamous Cell Carcinoma by Regulating ATR and NLRP3 Inflammasome

PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB “Super-Stimulation”

TNFα Signaling Is Increased in Progressing Oral Potentially Malignant Disorders and Regulates Malignant Transformation in an Oral Carcinogenesis Model

Bone Marrow Soluble Immunological Mediators as Clinical Prognosis Biomarkers in B-Cell Acute Lymphoblastic Leukemia Patients Undergoing Induction Therapy

The Prognostic Value of a Tumor Microenvironment-Based Immune Cell Infiltration Score Model in Colon Cancer

Metabolic Modifications, Inflammation, and Cancer Immunotherapy

Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report

Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?